Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline in Fontan Circulation (THIEF)
NCT05717049Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Feb 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of theophylline in congenital heart disease (CHD), sponsored by Oslo University Hospital. Started Feb 2023; status: completed.
02
Drugs
theophylline
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT05717049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05717049.